Nexalin Technology, Inc. (NXL) Stock Analysis

Company Overview

The market values Nexalin Technology, Inc. (NXL) at $2.13M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 8 employees.

The 52-week range on file runs from $1.94 to $49.50. The most recent close on file for NXL is $2.03, dated October 21, 2026. That is −$0.11 (−5.14%) against the previous close. The latest close sits 4.64% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $301.65K. That is +78.78% against the prior fiscal year, when revenue was $168.72K. The same year closed with a net loss of $8.22M. Earnings per share on a trailing basis come to −14.1.

Across the 4 fiscal years on file, revenue moves from $1.32M in 2022 to $301.65K in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 9.8 times revenue. On price-to-sales that is 3.9 times the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −95.61%. Across 3 years the annualized return works out at −39.33%. Beta against the wider market is reported at 4.11. Annualized volatility over the trailing 4 years is 167.7%.

Growth & Income

The record shows no dividend for NXL.

So far in 2026 the total return is −87.87%. The strongest complete calendar year on file is 2024 at +581.48%; the weakest is 2025 at −79.78%. Of the 3 complete calendar years on file, 1 finished higher.